Supriya Lifescience Announces Bail Granted to GM Sales & Marketing Under NDPS Act
Supriya Lifescience Ltd · Others (Uncategorized) · 03 Nov 2026, 2:38 am
Supriya Lifescience Announces Bail Granted to GM Sales & Marketing Under NDPS Act Supriya Lifescience announced that Mr. Sreekant Sreedharan, General Manager – Sales & Marketing, was granted bail by the Sessions Court on 2nd Nov'26 in ongoing judicial proceedings under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. The bail is subject to court-specified conditions. The company stated that the court order has no material impact on its operations and affirmed it will continue to update stock exchanges on further developments.
Original exchange filing (PDF)
More announcements from Supriya Lifescience Ltd
- Earnings Call Transcript is enclosed herewith. · 13 Nov 2026
- Outcome of the Results Earning Call for Quarter and Half year ended September 30, 2026 is enclosed herewith. · 07 Nov 2026
- Press Release is enclosed herewith. · 07 Nov 2026
- Investor Presentation is enclosed for the Results Earnings Call for quarter and half year ended September 30, 2026. · 06 Nov 2026
- Change In Management - Appointment of Senior Management Personnel of the Company. · 06 Nov 2026
- Please find enclosed. · 06 Nov 2026
- Supriya Lifescience Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 06 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held .... · 06 Nov 2026
